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ABSTRACT
In platelets, PGHS-1-dependant formation of thromboxane A2
is an important modulator of platelet function and a target for
pharmacological inhibition of platelet function by aspirin.
Since platelets are anucleated cells, we have used the
immortalized human megakaryoblastic cell line MEG-01,
which can be induced to differentiate into platelet-like
structures upon addition of TPA as a model system to study
PGHS-1 gene expression. Using a specific antibody to PGHS-1
we have developed a technique using immunofluorescence
microscopy and analysis of multiple digital images to monitor
PGHS-1 protein expression as MEG-01 cells were induced to
differentiate by a single addition of TPA (1.6 x 10
-8 M) over a
period of 8 days. The method represents a rapid and
economical alternative to flow cytometry. Using this technique
we observed that TPA induced adherence of MEG-01 cells,
and only the non-adherent TPA-stimulated cells demonstrated
compromised viability. The differentiation of MEG-01 cells
was evaluated by the expression of the platelet-specific cell
surface antigen, CD-41. The latter was expressed in MEG-01
cells at the later stages of differentiation. We demonstrated a
good correlation between PGHS-1 expression and the overall
level of cellular differentiation of MEG-01 cells. Furthermore,
PGHS-1 protein expression, which shows a consistent increase
over the entire course of differentiation can be used as an
additional and better index by which to monitor megakaryocyte
differentiation.
INTRODUCTION
The enzyme prostaglandin endoperoxide H synthase (PGHS)
catalyses the synthesis of prostaglandin H2 (PGH2), which is
then converted in platelets to the potent aggregatory substance
thromboxane A2 [1]. Study of the PGHS enzyme is important
because it is the pharmacological target for aspirin. Two PGHS
isozymes, PGHS-1 and PGHS-2, are known to exist [1-3] and
each is encoded by a different gene. PGHS-1 and PGHS-2 both
catalyze the conversion of arachidonic acid to PGH2,a n dt h e
activity of both enzymes is inhibited by aspirin [4,5]. The
major difference between the two PGHS isozymes is in their
expression. PGHS-2 is undetectable in most resting tissues [6].
However, PGHS-2 expression is induced in response to
inflammation [7] and it is therefore referred to as the inducible
form of the enzyme [6]. In contrast, PGHS-1 is detectable in
most tissues and is therefore the constitutive form of the
enzyme [6].
Blood platelets are anucleated cells and represent one of the
richest sources of PGHS-1 enzyme. Little is known about the
mechanisms by which the platelet’s precursor cells, the
megakaryocytes, regulate the expression of the PGHS-1 gene
so that significant amounts of PGHS-1 enzyme are found in the
mature platelet. Many markers specific to the different
maturational stages of megakaryocytes have been identified
[8]. The objective of this study was to determine at what stage
during megakaryopoiesis cells begin to express PGHS-1
enzyme in comparison to the platelet specific antigen
GPIIb/IIIa (CD-41) [9-11]. As a model system we chose to use
the immortalized human megakaryoblastic cell line, MEG-01
[12].D.J. Franks et al. 55
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Treatment of suspension cultures of MEG-01 cells with TPA
(12-0-tetradecanoylphorbol-13-acetate) induces some of the
cells to adhere to the substratum and to begin a process of
differentiation that terminates after 7 to 10 days [13]. Using
DAPI (4’,6-diamidino-2-phenylindole) as a fluorescent nuclear
marker, we assessed cell number and specific antibodies to
PGHS-1 and CD-41 in order to identify cells expressing these
two megakaryocyte differentiation markers in both adherent
and non-adherent cells in control and TPA-treated MEG-01
cells.
Flow cytometry is undoubtedly the best technique for the
quantification of data from fluorescent labeled cells. However
flow cytometry of multiply labeled cells is often technically
difficult. We used DAPI as a nuclear label so as to achieve
sufficient color separation between nuclei and PGHS-1, which
is a cytosolic enzyme. Our flow cytometer is not equipped with
a UV laser, and therefore was not able to detect DAPI
fluorescence. Therefore, it would not have been possible for us
to perform the type of study proposed by flow cytometry. As
an alternative, we developed a quantitative fluorescence
microscopic technique using extensive image analysis that
enabled us to obtain quantitative data that clearly showed that
PGHS-1 expression is an excellent marker of early
megakaryocyte differentiation.
MATERIALS AND METHODS
Materials
Polyclonal rabbit-anti PGHS-1 IgG raised against the ovine
PGHS-1 amino acid sequence L272-Q283 (LMHYPRGIPPQ-
C) which is 100% identical to the corresponding human
peptide sequence was a gift from Dr. W.L. Smith, Michigan
State University and was at a stock concentration of 0.5
mg/mL. Monoclonal mouse anti-human platelet CD41 (5B12)
was obtained from DAKO (Carpintera, CA). Rhodamine-
conjugated donkey-anti rabbit IgG (H+L) and Cy3-conjugated
secondary donkey-anti-mouse IgG (H+L) were purchased from
Jackson ImmunoResearch Laboratories, Inc. (West Grove,
PA).
Cell Culture
MEG-01 cells were obtained from the American Type Culture
Collection (ATCC, Manassas, VA). Cells for immunolabelling
studies were seeded at a concentration of 2 x 10
5 cells/mL into
Falcon 6-well tissue culture dishes containing 18 mm
2 glass
coverslips or 75 cm
2 tissue culture flasks containing 40 mL of
RPMI 1640 supplemented with 10% FBS in the absence of
antibiotics. In each case, the spent media was partially replaced
with fresh RPMI 1640 supplemented with 10% FBS every 4
days. Prior to analysis, the cells were cultured inside a
humidified incubator for 2 weeks in an atmosphere of 5% CO2
and air at a temperature of 37
oC. When indicated cultures were
treated with TPA dissolved in dimethylsulphoxide (DMSO) at
a final concentration of 1.6 x 10
-8 M. Controls were treated
with DMSO vehicle.
Separation of cell populations
MEG-01 cells in culture form three distinct populations;
nucleated cells that remain in suspension in the culture media,
nucleated cells that adhere to the substratum, and anucleated
platelet-like structures. In order to harvest the three cell
populations separately, the non-adherent cells were first
collected by removing the liquid media. Adherent cells were
rinsed once with culture media and the liquid media is pooled
with the non adherent fraction. The adherent cells are scraped
with a plastic policeman and resuspended in fresh media.
Platelet-like structures were then isolated from the non-
adherent and the adherent cell fractions by centrifugation [14].
Each fraction was centrifuged at 330 g for 5 min. to collect the
nucleated cells. The supernatants were centrifuged at 900 g for
15 min. to collect the anucleated platelet-like structures.
Following centrifugation, pellets were washed three times in
PBS and fixed for immunocytochemistry.
Immunocytochemistry
Detection of intracellular PGHS-1 was carried out by indirect
immunofluorescence. Adherent cells on coverslips were rinsed
in PBS and fixed with 2% paraformaldehyde in PBS for 45
min. The coverslips were then washed in PBS/10% FBS three
times for 5 min. Coverslips were incubated in a humid chamber
with polyclonal rabbit anti-PGHS-1 at a concentration of 0.01
mg/mL in the presence of PBS, 2% saponin, and 10% FBS.
Following the incubation with primary PGHS-1 antibody, the
coverslips were washed 3 times in PBS/10% FBS for 5 min.
The coverslips were washed twice more in PBS/10% FBS,
once in PBS and mounted onto microscope slides in 15 mLo f
Permafluor mounting media. In order to assess nonspecific
binding of the secondary antibody, the same procedure was
carried out in the absence of primary antibody. Anti-PGHS-1
antibody incubated with the antigenic peptide was also used as
a negative control.
For detection of CD-41, cells grown on coverslips were fixed
in Zamboni’s fixative (4% formaldehyde/14% picric acid in
PBS) for 45 min, washed in PBS and incubated in a humid
chamber for 45 min with monoclonal mouse anti-hCD-41 at a
1:100 dilution in PBS. The coverslips were then incubated in a
humid chamber for a further 45 min. with Cy3-labeled
secondary donkey anti-mouse IgG diluted 1:150 in PBS. After
three further washes in PBS the coverslips were incubated for 2
min. with DAPI (5 mg/mL) and mounted on glass microscope
slides in 15 mL of Permafluor. Nonspecific binding was
assessed in coverslips that were labeled with secondary
antibody only.
Non-adherent MEG-01 cells were collected by centrifugation
at 330g for 5 min. The media was discarded and the cell pellets
gently suspended in 10 mL of PBS at 37°C. The cells were re-D.J. Franks et al. 56
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centrifuged and re-suspended in 5 mL of PBS. 0.5 mL aliquots
of the cell suspensions were plated onto 18 mm
2 1.5 glass
coverslips that had been previously incubated at room
temperature for 10 min. with 1 mg/mL poly-L-lysine and
attached by further incubation for 1 min at room temperature.
The attached cells were fixed in paraformaldehyde/PBS and
labeled with anti-PGHS-1 and DAPI as described above.
Assessment of viability of adherent MEG-01 cells was
performed on cells grown on glass coverslips. Cells were
rinsed in PBS and incubated with propidium iodide (50 mg/mL)
for 5 min. Coverslips were then rinsed three times in PBS and
fixed in 2% paraformaldehyde in PBS for 45 min. The cells
were then washed three more times in PBS for 5 min and then
incubated for 2 min. with DAPI (5 mg/mL) The coverslips were
washed twice more in PBS before being mounted onto
microscope slides in 15 mL of Permafluor mounting media.
Non-adherent MEG-01 cells were attached to poly-L-lysine
coated coverslips as described above and the coverslips were
processed in the same way as for adherent MEG-01 cells.
Fluorescence Microscopy
Direct and indirect fluorescence of cells on coverslips were
viewed with an Olympus BX50 microscope. Images were
captured with a Sony CCD monochrome camera. DAPI
fluorescence of nuclei was visualized by excitation at 330-385
nm with a 420 nm barrier filter. Rhodamine and Cy3
fluorescence was visualized by excitation at 510-550 nm with a
barrier of 590 nm. For analysis all images were viewed and
captured at 200X magnification. Triplicate slides were
prepared at each time point, and for each slide, triplicate 425 x
425 micron fields were randomly selected containing 100 to
300 cells. The same field was used to identify total cells and
cells expressing PGHS-1 and CD-41. Image analysis was
performed using Image-Pro Plus (Media Cybernetics, Silver
Spring, Maryland).
(Sections reprinted from [15] "Characterization of
prostaglandin endoperoxide H synthase-1 enzyme expression
during differentiation of the megakaryocytic cell line MEG-01"
by Mroske et al.i nExperimental Hematology. 2000; 28: 411-
421. Copyright (2000), with permission from Elsevier
Science.)
RESULTS AND DISCUSSION
PGHS-1 expression during megakaryocyte
differentiation.
We first attempted to determine if the overall level of PGHS-1
enzyme increase as MEG-01 cells are induced to differentiate
into platelet-like structures. We separated PGHS-1 by SDS-
PAGE from the three populations of cells forming cultured
MEG-01cells. PGHS-1 migrates as a 70 kDa band and we
quantified the level of the enzyme by calculating the ratio of
the PGHS-1 band intensity over that of m-tubulin for each cell
population. In control cells, the levels of PGHS-1 enzyme were
5 times higher in the platelet fraction and 2 times higher in the
adherent fraction compared to the floating cells [15]. After 8
days of TPA treatment, the level of PGHS-1 enzyme increased
in the three cell populations and the platelet fraction, which
represents the latest stage of differentiation, contained the
greatest amount of enzyme compared to the less differentiated
cells found in the non-adherent fraction. Thus, by separating
the three cell populations forming MEG-01 cells in culture we
established that the levels of PGHS-1 enzyme correlated with
the differentiation state of these cells; i.e., the more
differentiated were the cells the greater were the levels of
PGHS-1 [15].
Having established by Western immunoblotting that the levels
of PGHS-1 enzyme were higher in more differentiated MEG-
01 cells as well as in TPA-treated cells [15], we analyzed cells
individually to determine whether a larger number of cells
actually expressed PGHS-1 or if the expression was higher per
cell. Since a component of differentiation in these cells
involves adherence to the substratum it was necessary to
examine both adherent and non-adherent cells (the platelet-like
structures could not be analyzed since they were not cellular
and represented a minor component) to determine the total
number of cells and to identify those expressing PGHS-1.
Therefore, at each time point, grayscale images for DAPI
Fig. 1: Time course of adherence and PGHS-1 expression in
control and TPA-treated MEG-01 cells. A: MEG-01 cell
adherence. Values at each time point were obtained by
determining the mean ± SE of three separate fields from three
individual slides. B: PGHS-1 protein expression profile. Values
at each time point were obtained by determining the mean ± SE
of three separate fields from three individual slides. Reprinted
from [15] "Characterization of prostaglandin endoperoxide H
synthase-1 enzyme expression during differentiation of the
megakaryocytic cell line MEG-01" by Mroske et al.i n
Experimental Hematology. 2000; 28: 411-421. Copyright
(2000), with permission from Elsevier Science.D.J. Franks et al. 57
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fluorescence and rhodamine fluorescence (for PGHS-1) were
collected.
A B
C D
Fig. 2: Phase contrast and immunofluorescence images
(400X magnification) of adherent MEG-01 cells treated
with TPA for 4 days. A: Phase contrast image. Arrows show
MEG-01 cells with unusual morphology. B: Dapi fluorescence
image of same field. Red arrow, binucleated MEG-01 cell;
yellow arrow, multinucleate MEG-01 cell. C: Rhodamine
fluorescence for PGHS-1 of same field. Yellow arrows indicate
fluorescence intensity above threshold; green arrows indicate
fluorescence below threshold. D: Cy3 fluorescence for CD-41.
Note the predominately plasma membrane localization. Yellow
arrows indicate fluorescence intensity above threshold; green
arrows indicate fluorescence below threshold.
Determination of total cells was relatively straightforward.
MEG-01 cells are nucleated, thus treatment with DAPI labeled
the nuclei in all cells. However as differentiation progressed
the adherent cells undergo marked changes in morphology
(Fig. 2A) and in the late stages of differentiation develop
irregular shaped, lobular or fragmented nuclei (Fig. 2B.). TPA-
treated MEG-01 cells also become polyploid [16]. Thus, the
DAPI staining of the nuclei was not uniform in intensity. By
inverting the image and applying a local equalization filter with
a narrow pixel window we were able to enhance pixel contrast
and correct for the difference in labeling intensity. Application
of a 5x5 kernel size low pass filter at full strength softened the
image so that lobular and fragmented nuclei were merged into
a single object. To eliminate pixel noise from the camera and
spurious fluorescence we only accepted objects that had a size
greater than 30mm
2.
PGHS-1 fluorescence was uniform and localized throughout
t h ec y t o p l a s mo fM E G - 0 1c e l l s( F i g .2 C ) .T h u s ,t oe s t i m a t et h e
number of cells expressing PGHS-1 we used the outline
obtained from the DAPI fluorescence image and applied it to
the rhodamine fluorescence image. No image filtering was
applied. The appropriate grayscale threshold value was
obtained by taking the average pixel intensity obtained from
fields of MEG-01 cells that were not incubated with primary
antibody. Only objects having an average pixel value above
this threshold were counted. Thus, only the cells that expressed
PGHS-1 were counted.
The results obtained for adherent cells are shown in Fig. 1.
Some control MEG-01 cells did adhere to the substratum by 2
days (Fig. 1A). By contrast, TPA-treated MEG-01 cells rapidly
adhered to the substratum and adherence was maximal at 2
days (Fig. 1A). Subsequently the number of adherent cells
declined so that by 8 days the number of adherent cells
approached the control value. In control MEG-01 cells, there
was a gradual increase in PGHS-1 expression after 2 days but it
never reached more than 20% of the total cell number (Fig.
1B). However, in TPA-treated MEG-01 the percentage of cells
expressing PGHS-1 decreased at 2 days and then increased to
60% at 4 days and remained at this level up to 8 days (Fig. 1B).
On first examination, the decrease in the percentage of cells
expressing PGHS-1 in TPA-treated MEG-01 cells at day 2
appeared surprising. However, from the data in Fig. 1A, day 1
to 2 is the period of maximum adherence, hence the total
number of MEG-01 cells is rapidly increasing without any
change in PGHS-1 expression. Therefore, the increase in
PGHS-1 expression does not in fact begin until after adherence
is complete. Thus a decrease in the percentage of cells staining
positive for PGHS-1 at day 2 would be expected.
The above results strongly indicated that PGHS-1 expression
was associated with adherence to the substratum. Nevertheless,
we wanted to determine whether there was an increased PGHS-
1 expression in the non-adherent cells. We used the same
image analysis algorithm for this analysis even though the
analysis of these cells was simpler, since because they were
suspension cultures their DAPI fluorescence was more
uniform. As would be expected none of the non-adherent cells
showed significant PGHS-1 staining (data not shown).
CD-41 protein expression during megakaryocyte
differentiation
Since one of the widely used markers for megakaryocyte
differentiation is CD-41 [9], we wanted to determine how its
expression compared with that of PGHS-1 in control and TPA-
treated MEG-01 cells. To accurately assess the percentage of
total cells labeled positive for CD-41, a modification to the
method used for PGHS-1 was used. Since the PGHS-1
fluorescence was cytoplasmic, applying the outline from the
filtered DAPI image also identified cells expressing PGHS-1.
CD-41 fluorescence is predominately associated with the
plasma membrane (Fig. 2D), therefore the DAPI outline could
not be used to identify CD-41 positive cells. Instead the Cy3
fluorescence image was inverted and filtered using a local
equalization filter with a wide pixel window. With this methodD.J. Franks et al. 58
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we were able to normalize the fluorescence intensity and
identify all the Cy3 labeled cells. Application of a 5x5 kernel
size low pass filter at full strength softened the image and
eliminated noise. This outline was then applied to the original
Cy3 fluorescence image. The appropriate grayscale threshold
value was obtained by taking the average pixel intensity
obtained from fields of cells that were not incubated with
primary antibody. Only objects having an average pixel value
above this threshold were counted. To eliminate noise and
spurious fluorescence only objects having a size greater than
60 mm
2 were accepted. Thus, only the cells that expressed CD-
41 were counted.
The results obtained for adherent cells are shown in Fig. 3. CD-
41 expression occurred much later in MEG-01 cell
differentiation than PGHS-1. There was no significant increase
in CD-41 expression until after day 6 in both control and TPA-
treated MEG-01 cells. In contrast to PGHS-1 enzyme, there
was little effect of TPA treatment on CD-41 expression. In fact,
in TPA-treated cells CD-41 expression actually started later
than in the controls, though the same number of positively
stained cells (35%) was reached in both control and TPA-
treated by day 8.
We conclude that PGHS-1 enzyme is a much better indicator of
TPA-induced megakaryocyte differentiation than the platelet-
specific cell surface marker CD-41 [9]. CD-41 is thought to be
expressed on the plasma membrane of very mature
megakaryocyte cells prior to platelet release [17,18]. CD-41
staining may be a poor marker of differentiation in MEG-01
cells since the cells may never reach this level of maturity. In
non-adherent MEG-01 cells there was insignificant staining of
CD-41 in either control or TPA-treated cells (data not shown).
MEG-01 cell viability
Given the fact that the number of both adherent and non-
adherent TPA-treated MEG-01 cells decreased over the 8 day
time course we wanted to determine whether the cells remained
viable during this time. To do this MEG-01 cells were
incubated with propidium iodide prior to fixation. Since
propidium iodide is not permeable to viable cells, only cells
having compromised membrane integrity would be labeled.
The cells were then fixed and incubated with DAPI to label the
entire cell population. DAPI and propidium iodide fluorescent
images were collected and analyzed in the same way as for
PGHS-1. To eliminate noise only propidium iodide labeled
cells with an average pixel value greater than 50 were counted.
There was no loss of viability in either control or TPA-treated
adherent MEG-01 cells (data not shown). Nevertheless, the
data in Fig. 1A indicate that in TPA-treated MEG-01 cells, the
number of adherent cells decreases after 2 days even though
the percentage of cells expressing PGHS-1 remains constant.
We assume that cells that adhere but do not achieve any
significant PGHS-1 expression must detach from the
substratum and are lost when the coverslips are washed prior to
Fig. 3: Time course of CD-41 expression in control and
TPA-treated adherent MEG-01 cells. Values at each time
point were obtained by determining the mean ± SE of three
separate fields from three individual slides. Reprinted from
[15] "Characterization of prostaglandin endoperoxide H
synthase-1 enzyme expression during differentiation of the
megakaryocytic cell line MEG-01" by Mroske et al.i n
Experimental Hematology. 2000; 28: 411-421. Copyright
(2000), with permission from Elsevier Science.
Fig. 4: Assessment of viability in control and TPA-treated
non-adherent MEG-01 cells. Values at each time point were
obtained by determining the mean ± SE of three separate fields
from three individual slides. Reprinted from [15]
"Characterization of prostaglandin endoperoxide H synthase-1
enzyme expression during differentiation of the
megakaryocytic cell line MEG-01" by Mroske et al.i n
Experimental Hematology. 2000; 28: 411-421. Copyright
(2000), with permission from Elsevier Science.D.J. Franks et al. 59
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fixation. We did not follow this population, but it is probable
that these cells are non viable since substantial apoptosis-like
morphology is seen in MEG-01 cells in the later stages of
differentiation. As shown in Fig. 4, 80% of the TPA-treated
non-adherent MEG-01 cells lost viability after 2 days, whereas
there was a very slight (10%) loss of viability in the control.
Conclusions
We have established an immunocytochemical and image
analysis method by which the number of cells expressing the
enzyme PGHS-1 can be monitored throughout the
differentiation of megakaryoblastic cells into platelet-like
structures. This method also allowed us to simultaneously
monitor the expression of CD-41 a known marker of
megakaryocyte differentiation. Cell number and viability could
also be determined. The method presents a viable alternative to
flow cytometry since the cost is minimal and requires only a
fluorescence microscope and video camera. Once the images
are collected, the analysis can be automated and can be
performed in a minimum amount of time.
The two main observations we have made with this technique
are. 1; PGHS-1 enzyme expression is higher in the more
differentiated population of MEG-01 cells and 2; when MEG-
01 cells are induced to differentiate upon addition of TPA, the
expression of PGHS-1 enzyme increases only in the adherent
cell populations that are destined to differentiate into platelet-
like structures. Relative to CD-41, a widely used marker of
megakaryocyte differentiation, PGHS-1 enzyme expression
increases consistently over the entire course of differentiation.
It has been suggested that non-adherent MEG-01 cells remain
at an earlier stage of differentiation than adherent cells based
on morphological and biochemical criteria including the
expression of the glycoprotein Ib [13]. Our results on PGHS-1
expression strongly support this premise. MEG-01 cells in
culture represent a useful model to study maturation
mechanisms and differentiation in vitro. T h ep r o c e s sa p p e a r st o
be complete in that formation of platelet-like structures occurs
but with a lower efficiency compared to the in vivo situation
[19, 20].
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PROTOCOL
Preparation of cells for immunocytochemistry
Adherent cells
1. Grow MEG-01 cells directly on 18 mm
2 glass coverslips.
2. Rinse cells with 0.5 ml PBS at room temperature.
3. Add 0.5 ml of a 2% paraformaldehyde solution in PBS to the coverslips and incubate for 45 min.
4. Rinse the coverslips with PBS/10% FBS for 5 min. Repeat 3 times.
5. Add the primary antibody at a concentration of (0.01 mg/ml) in 200 ml of a solution of PBS, 2% saponin and
10% FBS. Incubate 1 hr. in a humid chamber.
6. Wash the coverslips 3 times with PBS/10% FBS.
7. Add 0.5 ml of the secondary antibody (anti-IgG) diluted 1:30 in PBS/2% saponin/10% FBS.
8. Incubate 45 min. in a humid chamber.
9. Rinse the coverslips 3 times with PBS/10% FBS.
10. Add 0.5 ml of DAPI (5µg/mL) in PBS/2% saponin/10% FBS.
11. Rinse 3 times with PBS/10% FBS.
12. Mount onto microscope slides in 15 ml of Permafluor mounting media.
Non adherent cells
13. Collect non-adherent MEG-01 cells by centrifugation at 330 x g for 5 min.
14. Resuspend the cell pellet in 10 ml of PBS and re-centrifuge at 330 x g for 5 min.
15. Resuspend the cell pellet in 5 ml of PBS.
16. Apply 0.5 ml aliquots of the cell suspensions to 18 mm
2 glass coverslips coated with 1 mg/ml poly-L-lysine.
Incubating the suspensions for 1 min. at room temperature cause the floating MEG-01 to become attached to the
coverslips.
17. Repeat from step 2.
Image Analysis
Images were analysed using ImagePro Plus (Media Cybernetics). The macro used for the analysis of DAPI/PGHS-1
labeled cells and DAPI/CD-41 labeled MEG-01 cells is reproduced below. Macros were written in ImagePro Plus Auto-
Pro script.
Sub Total DAPI_PGHS()
Dim DapiName As String * 255
Dim RhodName As String * 255
Dim X As Integer
Dim DirSearch As Integer
Dim TotalObj As Integer
Dim PGHSPos As Integer
Dim Intens As Integer
ret = IpSCalShow(1)
ret = IpSCalSelect("20X (monochrome)")
ret = IpSCalShow(0)
ret = IpOutputClear()
ret = IpOutputShow(1)
ret = IpStGetInt("Enter the intensity threshold to be used for PGHS +ve cells", Intens, 100, 5, 254)
If ret = 0 Then End
X=0
DirSearch = IpStSearchDir("D:\Meg01\Dapi", "*.BMP" ,X, DapiName)
DirSearch = IpStSearchDir("D:\Meg01\Rhodamine", "*.BMP" ,X, RhodName)
Do While DirSearch = 1
ret = IpWsLoad(dapiName, ".BMP")
ret = IpDocMove(0, 0)
ret = IpWsLoad(RhodName, ".BMP")
ret = IpDocMove(600, 0)
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ret = IpLutSetAttr(LUT_CONTRAST, _2)
ret = IpHstEqualize(EQ_BESTFIT)
ret = IpLutApply()
ret = IpFltGauss(10, 10, 1)
ret = IpBlbShow(1)
ret = IpBlbLoadSetting("C:\Program Files\IPWin3\Data\pi.env")
ret = IpBlbSetAttr(BLOB_AUTORANGE,0)
ret = IpBlbSetRange(0, 100)
ret = IpBlbCount()
ret = IpBlbUpdate(0)
ret = IpBlbSplitObjects(1)
ret = IpBlbSplitObjects(0)
ret = IpBlbGet (GETNUMOBJ, 0, 1, TotalObj)
ret = IpBlbSaveOutline("C:\Program Files\IPWin3\Data\dapi.out")
ret = IpAppSelectDoc(1)
ret = IpBlbLoadSetting("C:\Program Files\IPWin3\Data\rhod.env")
ret = IpBlbSetFilterRange(BLBM_DENSITY, Intens, 255)
ret = IpBlbLoadOutline("C:\Program Files\IPWin3\Data\dapi.out")
ret = IpBlbGet (GETNUMOBJ, 0, 1, PGHSPos)
Print DapiName, chr$(9), TotalObj, chr$(9), PGHSPos
ret = IpBlbShow(0)
ret = IpMacroWait(10)
ret = IpAppCloseAll()
X=X+1
DirSearch = IpStSearchDir("D:\Meg01\Dapi", "*.BMP" ,X, DapiName)
DirSearch = IpStSearchDir("D:\Meg01\Rhodamine", "*.BMP" ,X, RhodName)
Loop
Print "Intensity range ", Intens,"_255"
ret = IpDde(DDE_SET, "col", "1")
ret = IpDde(DDE_SET, "row", "3")
ret = IpOutputSave("", S_DDE)
End Sub
Sub TotalDapi_CD41()
Dim DapiName As String * 255
Dim RhodName As String * 255
Dim X As Integer
Dim DirSearch As Integer
Dim TotalObj As Integer
Dim CD41Pos As Integer
Dim Intens As Integer
ret = IpSCalShow(1)
ret = IpSCalSelect("20X (monochrome)")
ret = IpSCalShow(0)
ret = IpOutputClear()
ret = IpOutputShow(1)
ret = IpStGetInt("Enter the intensity threshold to be used for PGHS +ve cells", Intens, 100, 5, 254)
If ret = 0 Then End
X=0
DirSearch = IpStSearchDir("D:\Meg01\Dapi", "*.BMP" ,X, DapiName)
DirSearch = IpStSearchDir("D:\Meg01\Rhodamine", "*.BMP" ,X, RhodName)
Do While DirSearch = 1
ret = IpWsLoad(dapiName, ".BMP")
ret = IpDocMove(0, 0)
ret = IpWsLoad(RhodName, ".BMP")
ret = IpDocMove(600, 0)
ret = IpAppSelectDoc(0)
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ret = IpFltLocHistEq(100, 64, 6, 1.0)
ret = IpFltLoPass(5, 10, 1)
ret = IpBlbShow(1)
ret = IpBlbLoadSetting("C:\Program Files\IPWin3\Data\dapi.env")
ret = IpBlbSetAttr(BLOB_AUTORANGE,0)
ret = IpBlbSetRange(0, 50)
ret = IpBlbCount()
ret = IpBlbUpdate(0)
ret = IpBlbSplitObjects(1)
ret = IpBlbSplitObjects(0)
ret = IpBlbGet (GETNUMOBJ, 0, 1, TotalObj)
ret = IpAppSelectDoc(1)
ret = IpWsDuplicate()
ret = IpLutSetAttr(LUT_CONTRAST, _2)
ret = IpFltLocHistEq(256, 64, 6, 5.0)
ret = IpFltLoPass(5, 10, 1)
ret = IpBlbLoadSetting("C:\Program Files\IPWin3\Data\CD41.env")
ret = IpBlbSetAttr(BLOB_AUTORANGE,0)
ret = IpBlbSetRange(0, 100)
ret = IpBlbCount()
ret = IpBlbUpdate(0)
ret = IpBlbSplitObjects(0)
ret = IpBlbSaveOutline("C:\Program Files\IPWin3\Data\CD41.out")
ret = IpDocClose()
ret = IpBlbLoadSetting("C:\Program Files\IPWin3\Data\rhod.env")
ret = IpBlbSetFilterRange(BLBM_DENSITY, Intens, 255)
ret = IpBlbLoadOutline("C:\Program Files\IPWin3\Data\CD41.out")
ret = IpBlbGet (GETNUMOBJ, 0, 1, CD41Pos)
Print DapiName, chr$(9), TotalObj, chr$(9), CD41Pos
ret = IpBlbShow(0)
ret = IpMacroWait (20)
ret = IpAppCloseAll()
X=X+1
DirSearch = IpStSearchDir("D:\Meg01\Dapi", "*.BMP" ,X, DapiName)
DirSearch = IpStSearchDir("D:\Meg01\Rhodamine", "*.BMP" ,X, RhodName)
Loop
Print "Intensity range ", Intens,"_255"
ret = IpDde(DDE_SET, "col", "1")
ret = IpDde(DDE_SET, "row", "3")
ret = IpOutputSave("", S_DDE)
End Sub